Gastroenterology Billing in 2026

Colonoscopy Screening vs. Diagnostic, Polypectomy, and Anesthesia Coding

Published May 23, 2026 · 11 min read · By Yagnesh Dave

Colonoscopy is the highest-volume elective procedure in American medicine, with over 19 million performed annually. It's also one of the most frequently miscoded. The distinction between a screening colonoscopy and a diagnostic colonoscopy, and what happens to that coding when polyps are found, directly affects patient cost-sharing, reimbursement rates, and ACA compliance. The American College of Gastroenterology's 2025 practice survey found that 28% of GI practices are still coding screening-turned-therapeutic colonoscopies incorrectly, creating a pattern of patient complaints, insurance appeals, and downstream revenue loss. The financial stakes here are real: a recurring gap in this area adds up to lost or delayed revenue every month.

At RCMAXIS, our gastroenterology billing specialists manage claims for single-specialty GI practices, ambulatory endoscopy centers, and hospital-based GI programs. Here's everything you need to bill GI procedures correctly in 2026.

1. Screening vs. Diagnostic Colonoscopy: The Foundational Distinction

The purpose of the colonoscopy at the time of scheduling, not the findings, determines whether the procedure is coded as screening or diagnostic. If the patient presents for a routine colorectal cancer screening with no symptoms and no prior history of polyps or colorectal disease, it is a screening colonoscopy. If the patient presents with symptoms (rectal bleeding, change in bowel habits, abdominal pain), a prior polyp history requiring surveillance, or a personal history of colorectal cancer, it is diagnostic.

Screening Colonoscopy Code Reference

• G0121: Colorectal cancer screening, colonoscopy on individual not meeting high-risk criteria, average-risk Medicare patients (age 45+ with no risk factors)
• G0105: Colorectal cancer screening, colonoscopy on individual at high risk, prior polyp history, family history of colorectal cancer, personal history of CRC
• 45378: Colonoscopy, flexible, proximal to splenic flexure, the commercial insurance screening code (used when payer doesn't accept G codes)

Diagnostic Colonoscopy Code Reference

• 45378: Diagnostic colonoscopy, no intervention, also used commercially for diagnostic studies
• 45380: Colonoscopy with biopsy, single or multiple
• 45381: Colonoscopy with directed submucosal injection
• 45382: Colonoscopy with control of bleeding
• 45384: Colonoscopy with removal of tumor/polyp by hot biopsy forceps
• 45385: Colonoscopy with removal of tumor/polyp by snare technique
• 45388: Colonoscopy with ablation of tumor/polyp/lesion

2. The Screening-Turned-Therapeutic Rule and Patient Cost-Sharing

This is the most important, and most commonly misunderstood, rule in GI billing. When a patient schedules a screening colonoscopy but polyps are found and removed during the same procedure, the procedure is no longer purely screening. How this affects billing depends entirely on the payer.

Medicare (and Plans Following Medicare)

Under Medicare, when a screening colonoscopy is converted to a therapeutic procedure (polyp removed), Medicare waives the patient's cost-sharing for the screening portion. You bill the therapeutic code (e.g., 45385) with the PT modifier to indicate it began as a planned screening. The patient pays nothing for the screening intent, but may owe cost-sharing on the therapeutic component depending on their plan.

• Bill: 45385 with modifier PT (colorectal cancer screening test becoming a diagnostic test or therapeutic intervention)
• The PT modifier triggers Medicare to apply screening benefit rules; patient copay is waived for the screening portion
• Don't bill G0121 with 45385, the therapeutic code replaces the screening code entirely when an intervention occurs

ACA-Compliant Commercial Plans

Under the Affordable Care Act, preventive services including colorectal cancer screenings must be covered without cost-sharing. However, when a screening becomes therapeutic, most commercial payers apply cost-sharing to the upgraded diagnostic/therapeutic code. Use modifier 33 to indicate a preventive service and request the payer apply no cost-sharing.

• Bill: 45385 with modifier 33 (preventive service)
• Modifier 33 tells the payer this began as an ACA-mandated preventive screening; patient cost-sharing should be waived per ACA requirements
• Not all commercial payers honor modifier 33 for converted screenings, know your payer contracts and appeal when cost-sharing is incorrectly applied

3. Polypectomy Coding: Technique Determines the Code

Polypectomy code selection is based on the removal technique, not the polyp size or pathology result. Using the wrong technique code, particularly using 45380 (biopsy) when a snare polypectomy (45385) was performed, results in systematic undercoding worth thousands per month for an active GI practice.

Polypectomy Technique Reference

• 45380: Biopsy, cold biopsy forceps only; no resection or destruction. Use when the intent is tissue sampling, not removal
• 45384: Hot biopsy forceps or bipolar cautery, removal of small polyps (≤5 mm) using electrocautery through the biopsy channel
• 45385: Snare technique, cold snare or hot snare polypectomy; the most common polypectomy code for lesions >5 mm
• 45388: Ablation, laser, argon plasma coagulation, or other energy-based destruction without mechanical removal
• 45389: Endoscopic mucosal resection (EMR), en bloc or piecemeal resection of flat or sessile lesions using inject-and-cut technique

Multiple Polyps in the Same Session

When multiple polyps are removed using different techniques (e.g., snare polypectomy for one lesion and hot biopsy for another), bill the highest-value code as the primary and add the secondary technique code with modifier 59. Don't bill the same polypectomy code multiple times in a single session; colonoscopy codes are all-or-nothing per session, not per polyp.

4. Upper GI Endoscopy (EGD) Coding

Esophagogastroduodenoscopy (EGD) coding follows the same session-level, technique-based structure as colonoscopy. The base diagnostic EGD code (43239 for biopsy, 43235 for diagnostic only) is replaced, not supplemented, by the therapeutic code when an intervention is performed.

Common EGD Code Reference

• 43235: Upper GI endoscopy, flexible, transoral, diagnostic, no biopsy or intervention
• 43239: EGD with biopsy, single or multiple
• 43248: EGD with insertion of guidewire followed by dilation over guidewire
• 43249: EGD with balloon dilation of esophagus (≤30 mm)
• 43255: EGD with control of bleeding, any method
• 43270: EGD with ablation of tumor/polyp/lesion, Barrett's esophagus radiofrequency ablation

5. ERCP: The Most Complex GI Billing

Endoscopic retrograde cholangiopancreatography (ERCP) is the most technically complex and highest-reimbursed GI procedure. ERCP codes are structured by the combination of services performed (imaging, sphincterotomy, stone extraction, stent placement), and the bile duct vs. pancreatic duct access.

Key ERCP Code Reference

• 43260: ERCP, diagnostic, including minor papilla cannulation when performed
• 43261: ERCP with biopsy, single or multiple
• 43262: ERCP with sphincterotomy/papillotomy
• 43264: ERCP with removal of calculi/debris from biliary/pancreatic duct(s)
• 43274: ERCP with placement of stent into biliary or pancreatic duct
• 43275: ERCP with removal of foreign body/stent from biliary or pancreatic duct

ERCP codes are not additive, bill the single code that best represents the complete procedure performed. When multiple services are performed (sphincterotomy AND stone extraction), bill the code representing the most complex service (43264 includes stone extraction; if sphincterotomy was also performed, add 43262 with modifier 59 if medically distinct).

6. Anesthesia for GI Procedures: Propofol and CRNA Billing

Anesthesia for endoscopy, particularly propofol-based monitored anesthesia care (MAC), is subject to medical necessity requirements that vary by payer. Medicare covers anesthesia for average-risk screening colonoscopy only in patients meeting specific high-risk criteria. For all other average-risk patients, the endoscopist should not bill anesthesia separately; it is considered part of the procedure.

Anesthesia Coverage Rules for Colonoscopy

• Medicare covers MAC anesthesia for colonoscopy only when the patient has a documented medical condition creating anesthesia risk: severe COPD, morbid obesity, history of adverse anesthesia reaction, anticipated difficult procedure (prior colon surgery, loop), or prior failed colonoscopy without anesthesia
• Without these documented indications, billing 00810 (anesthesia for lower intestinal endoscopy) will be denied as not medically necessary
• Document the specific anesthesia indication in the pre-procedure assessment note, "routine screening without risk factors" will trigger denial
• CRNA services: bill under the CRNA's NPI with modifier QX (CRNA under physician supervision) or QZ (CRNA without supervision, in states with opt-out)

7. Capsule Endoscopy Billing

Capsule endoscopy (wireless capsule, swallowed by the patient) is used for small bowel evaluation when standard endoscopy can't reach the area of concern. Code selection depends on the anatomical area evaluated.

Capsule Endoscopy Codes

• 91110: Gastrointestinal tract imaging, intraluminal (capsule endoscopy), esophagus through ileum, full GI tract capsule
• 91111: Capsule endoscopy, esophagus only, used for Barrett's surveillance or varices screening in limited settings

Prior authorization is required by most commercial payers for capsule endoscopy. Documentation must show the indication (suspected small bowel bleeding, Crohn's disease evaluation, iron deficiency anemia workup after negative EGD and colonoscopy) and that standard endoscopy has already been performed and failed to identify the source.

RCMAXIS handles GI billing from straightforward screening colonoscopy programs to complex ERCP and capsule endoscopy practices. Our claims management workflow includes screening-vs-diagnostic classification at charge entry, automated PT/modifier 33 flagging, and payer-specific polypectomy code validation. For GI practices struggling with colonoscopy coding compliance, our coding audit service delivers a full retrospective review and prospective correction plan.

Gastroenterology Audit Exposure: Screening Status and Technique Coding

GI audits focus on two things: whether the colonoscopy was correctly classified and whether the technique code matches the procedure note. Screening status is set by the reason for the exam when it was scheduled, so a screening that turned therapeutic has to be coded and modified correctly, and the patient's cost-sharing has to follow. A reviewer compares your claim to the pathology report and the endoscopy note. The repayment math is unforgiving: a 3-year lookback on a recurring documentation gap here can grow into a sizable repayment demand, plus the cost of defending the appeal.

Technique coding is the second target. Polypectomy codes depend on how the polyp was removed, so a note that says snare while the claim says biopsy (or the reverse) is a mismatch either way. Anesthesia adds a third check, since propofol sedation has to be supported by the patient's condition. Contractors can look back three years, and endoscopy volume means one wrong rule repeats across hundreds of claims.

Frequently Asked Questions About Gastroenterology

How do you tell a screening colonoscopy from a diagnostic one?

The article says the purpose when the procedure is scheduled decides it, not the findings. A patient with no symptoms presenting for routine screening is a screening, even if polyps are found.

What happens when a screening colonoscopy becomes therapeutic?

The article calls it the most important and most misunderstood GI billing rule. The procedure is no longer purely screening once polyps are removed, which changes how the claim is coded and how the patient's cost-sharing applies, so both the claim and the patient conversation need to be handled correctly.

Is polypectomy coded by size or by technique?

By technique. The article notes that using the biopsy code (45380) when a snare polypectomy (45385) was performed produces an incorrect claim. Document the technique in the procedure note.